Stock Price
1,234.00
Daily Change
12.00 0.98%
Monthly
8.23%
Yearly
16.64%
Q1 Forecast
1,137.71

Aurobindo Pharma reported INR88.91B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Cipla INR 7.96B 39.9M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Hindustan Unilever INR 44.42B 16.29B Sep/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 41.52B 53.85B Sep/2025